RLAY Sale Disclosure
Bergstrom Donald A · SEC Form 4 · Filed Oct 30, 2026
Sale
Calculated transaction value
$41.93K
Bergstrom Donald A President, R&d
RLAY
Relay Therapeutics
RLAY
Transaction date
Oct 28, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 2 days later
RLAY daily price context
Close on/before transaction
$19.69
Oct 28, 2026
First close after public filing
$17.28
Nov 2, 2026
Return after filing · so far
+7.64%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,252 shares @ $18.62
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-441694
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$41.93K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relay Therapeutics, Inc. RLAY Current | Sale | Oct 28, 2026 | $41.93K |